StockSelector.com
  Research, Select, & Monitor Friday, July 20, 2018 12:48:39 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Merrimack Pharmaceuticals Inc$5.24($.06)(1.13%)

  Quote | Ranking | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

 Merrimack Reports First Quarter 2018 Financial Results
   Tuesday, May 08, 2018 6:25:00 AM ET

, May 8, 2018 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced its first quarter 2018 financial results for the period ended March 31, 2018.




































































































































Cision View original content:http://www.prnewswire.com/news-releases/merrimack-reports-first-quarter-2018-financial-results-300644057.html

SOURCE Merrimack Pharmaceuticals, Inc.



Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.